Trials / Recruiting
RecruitingNCT06757257
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 149 (estimated)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
Detailed description
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fostamatinib | oral administration |
Timeline
- Start date
- 2023-05-29
- Primary completion
- 2028-09-30
- Completion
- 2028-09-30
- First posted
- 2025-01-03
- Last updated
- 2025-01-03
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06757257. Inclusion in this directory is not an endorsement.